These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12134238)

  • 1. Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure.
    Delgado J; Leal M; Ruiz-Mateos E; Martínez-Moya M; Rubio A; Merchante E; de la Rosa R; Sánchez-Quijano A; Lissen E
    J Infect Dis; 2002 Aug; 186(3):410-4. PubMed ID: 12134238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
    De Rossi A; Walker AS; Klein N; De Forni D; King D; Gibb DM
    J Infect Dis; 2002 Aug; 186(3):312-20. PubMed ID: 12134227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
    Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
    J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus.
    Chavan S; Bennuri B; Kharbanda M; Chandrasekaran A; Bakshi S; Pahwa S
    J Infect Dis; 2001 May; 183(10):1445-54. PubMed ID: 11329124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death.
    Lecossier D; Bouchonnet F; Schneider P; Clavel F; Hance AJ;
    J Infect Dis; 2001 Apr; 183(7):1009-16. PubMed ID: 11237824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in thymic function with age and during the treatment of HIV infection.
    Douek DC; McFarland RD; Keiser PH; Gage EA; Massey JM; Haynes BF; Polis MA; Haase AT; Feinberg MB; Sullivan JL; Jamieson BD; Zack JA; Picker LJ; Koup RA
    Nature; 1998 Dec; 396(6712):690-5. PubMed ID: 9872319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.
    Kalayjian RC; Spritzler J; Pu M; Landay A; Pollard RB; Stocker V; Harthi LA; Gross BH; Francis IR; Fiscus SA; Tebas P; Bosch RJ; Valcour V; Lederman MM;
    J Infect Dis; 2005 Nov; 192(9):1577-87. PubMed ID: 16206072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy.
    Fernandez S; Nolan RC; Price P; Krueger R; Wood C; Cameron D; Solomon A; Lewin SR; French MA
    AIDS Res Hum Retroviruses; 2006 Feb; 22(2):163-70. PubMed ID: 16478398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection.
    Hazenberg MD; Otto SA; Cohen Stuart JW; Verschuren MC; Borleffs JC; Boucher CA; Coutinho RA; Lange JM; Rinke de Wit TF; Tsegaye A; van Dongen JJ; Hamann D; de Boer RJ; Miedema F
    Nat Med; 2000 Sep; 6(9):1036-42. PubMed ID: 10973325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes.
    Steffens CM; Al-Harthi L; Shott S; Yogev R; Landay A
    Clin Immunol; 2000 Nov; 97(2):95-101. PubMed ID: 11027449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential.
    Beq S; Delfraissy JF; Theze J
    Eur Cytokine Netw; 2004; 15(4):279-89. PubMed ID: 15627636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.
    Pariente N; Pernas M; de la Rosa R; Gómez-Mariano G; Fernández G; Rubio A; López M; Benito JM; López-Galíndez C; Leal M; Domingo E; Martinez MA; Mas A
    J Med Virol; 2004 Jul; 73(3):350-61. PubMed ID: 15170628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.